Brokerages forecast that Henry Schein, Inc. (NASDAQ:HSIC) will post earnings per share (EPS) of $1.66 for the current quarter, Zacks reports. Nine analysts have made estimates for Henry Schein’s earnings, with the lowest EPS estimate coming in at $1.60 and the highest estimate coming in at $1.70. Henry Schein reported earnings per share of $1.41 during the same quarter last year, which would suggest a positive year-over-year growth rate of 17.7%. The company is scheduled to announce its next earnings report on Tuesday, May 2nd.
On average, analysts expect that Henry Schein will report full year earnings of $7.25 per share for the current financial year, with EPS estimates ranging from $7.22 to $7.30. For the next fiscal year, analysts forecast that the company will post earnings of $8.01 per share, with EPS estimates ranging from $7.90 to $8.30. Zacks’ earnings per share calculations are a mean average based on a survey of sell-side research analysts that that provide coverage for Henry Schein.
Henry Schein (NASDAQ:HSIC) last released its earnings results on Tuesday, February 21st. The company reported $1.88 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.85 by $0.03. The company earned $3.12 billion during the quarter, compared to analyst estimates of $3.08 billion. Henry Schein had a return on equity of 18.15% and a net margin of 4.40%. The company’s revenue for the quarter was up 9.5% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.67 earnings per share.
Several research firms recently weighed in on HSIC. Craig Hallum began coverage on shares of Henry Schein in a research report on Tuesday. They issued a “hold” rating for the company. Deutsche Bank AG began coverage on shares of Henry Schein in a research report on Wednesday, March 15th. They issued a “hold” rating and a $174.00 price objective for the company. Jefferies Group LLC restated a “hold” rating and issued a $165.00 price objective on shares of Henry Schein in a research report on Tuesday, February 28th. Leerink Swann set a $183.00 price objective on shares of Henry Schein and gave the stock a “hold” rating in a research report on Wednesday, February 22nd. Finally, Zacks Investment Research upgraded shares of Henry Schein from a “sell” rating to a “hold” rating in a research report on Thursday, February 23rd. Ten investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus target price of $180.84.
In other Henry Schein news, SVP Lorelei Mcglynn sold 9,300 shares of Henry Schein stock in a transaction on Thursday, March 23rd. The shares were sold at an average price of $171.76, for a total transaction of $1,597,368.00. Following the completion of the sale, the senior vice president now owns 33,048 shares of the company’s stock, valued at approximately $5,676,324.48. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Donald J. Kabat sold 4,334 shares of Henry Schein stock in a transaction on Monday, February 27th. The stock was sold at an average price of $173.62, for a total transaction of $752,469.08. Following the sale, the director now directly owns 10,729 shares of the company’s stock, valued at approximately $1,862,768.98. The disclosure for this sale can be found here. Insiders have sold a total of 67,670 shares of company stock valued at $11,650,932 in the last ninety days. Company insiders own 1.27% of the company’s stock.
A number of hedge funds have recently added to or reduced their stakes in HSIC. Mitsubishi UFJ Trust & Banking Corp raised its stake in Henry Schein by 1.9% in the third quarter. Mitsubishi UFJ Trust & Banking Corp now owns 194,267 shares of the company’s stock worth $31,662,000 after buying an additional 3,616 shares in the last quarter. Baird Financial Group Inc. raised its stake in Henry Schein by 3.2% in the fourth quarter. Baird Financial Group Inc. now owns 35,994 shares of the company’s stock worth $5,461,000 after buying an additional 1,113 shares in the last quarter. Emerald Acquisition Ltd. raised its stake in Henry Schein by 23.8% in the third quarter. Emerald Acquisition Ltd. now owns 173,263 shares of the company’s stock worth $28,237,000 after buying an additional 33,350 shares in the last quarter. United Services Automobile Association raised its stake in Henry Schein by 4.1% in the third quarter. United Services Automobile Association now owns 42,075 shares of the company’s stock worth $6,857,000 after buying an additional 1,676 shares in the last quarter. Finally, Brown Advisory Inc. raised its stake in Henry Schein by 4.6% in the fourth quarter. Brown Advisory Inc. now owns 258,553 shares of the company’s stock worth $39,225,000 after buying an additional 11,270 shares in the last quarter. 90.91% of the stock is owned by hedge funds and other institutional investors.
Henry Schein (NASDAQ:HSIC) traded down 0.52% during mid-day trading on Monday, hitting $167.85. The stock had a trading volume of 217,649 shares. The company has a 50-day moving average price of $170.79 and a 200 day moving average price of $160.43. The company has a market cap of $13.29 billion, a P/E ratio of 27.12 and a beta of 1.02. Henry Schein has a 1-year low of $146.23 and a 1-year high of $183.00.
TRADEMARK VIOLATION WARNING: This piece was reported by sleekmoney and is the property of of sleekmoney. If you are accessing this piece on another site, it was copied illegally and republished in violation of United States and international copyright and trademark law. The original version of this piece can be accessed at http://sleekmoney.com/zacks-analysts-expect-henry-schein-inc-hsic-to-announce-1-66-earnings-per-share/1739699.html.
About Henry Schein
Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
This story was originally published by sleekmoney (http://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at http://sleekmoney.com/zacks-analysts-expect-henry-schein-inc-hsic-to-announce-1-66-earnings-per-share/1739699.html
Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.